Health knowledge and news provided by doctors.

Ingen Announces New Medical Technology, OxyAlert

Armen Hareyan's picture

Ingen Technologies's OxyAlert is with FDA and is expected to receive an "Exempt" status from the 510(k) filing in 60 days.

"After several months of evaluation, the Company is expected to receive an exemption from acquiring the 510(k) FDA requirement for OxyAlert. This allows OxyAlert to be immediately marketed through our exclusive distributor, Invacare Supply Group, Inc.," said Thomas Neavit, CFO.

Follow eMaxHealth on YouTube, Twitter and Facebook.
Please, click to subscribe to our Youtube Channel to be notified about upcoming health and food tips.

In August of 2007, the Invacare Supply Group, a Massachusetts corporation, formalized a master distributor agreement with Ingen to exclusively distribute its innovative new oxygen flow meter, Oxyview for a term of up to 3 years. The territory includes North America, South America, Europe, Asia, Australia and New Zealand.

Invacare Supply Group and its parent company, Invacare Corporation, introduced Oxyview at the MedTrade Convention in Orlando, Florida on October 4, 2007. According to the Director of Sales for Invacare Supply Group, Gary Tobey, Oxyview was a success.

OxyAlert is a new medical technology that uses wireless communication to send information related to the status of an oxygen delivery system to a remote receiver. Using a special microchip referred to as ZigBy, OxyAlert complies with the medical standards for wireless communication, and at the same time provides patients and caregivers the ability to distance themselves from the oxygen delivery system and still monitor the amount of oxygen being delivered.

"The Oxyview sales training meeting on October 2, 2007 with the sales team for Invacare Supply Group went very well. There is a tremendous amount of excitement and motivation with Invacare Supply Group regarding the Oxyview product, and we couldn't have dreamed of having a better leading distributor than the Invacare Supply Group."